Today, the SVP Tech. Op of BioTelemetry, Daniel Wisniewski, exercised options of BioTelemetry for $1.64M.
In addition to Daniel Wisniewski, one other BEAT executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on BioTelemetry’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $94.5 million and quarterly net profit of $5.98 million. In comparison, last year the company earned revenue of $55.88 million and had a net profit of $196K. Currently, BioTelemetry has an average volume of 231.5K.
The insider sentiment on BioTelemetry has been negative according to 27 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network.
